Posted on October 15th, 201810/15/18
A team of EVERSANA experts will be in Washington, DC today for the National Organization for Rare Disorders’ (NORD) 2018 Rare Summit. They will join more than 700 leaders from the FDA, NIH, industry, patient groups, payers and research institutions to address the industry’s shift to patient-centered, value-based care.
“We’re proud of our long standing partnership with NORD as they share our commitment to this important community. Every day, we are supporting our clients’ patients as they navigate the challenges of rare disease,” shares Kathi Henson, president of patient services, EVERSANA. “All stakeholders need to work together to bring more orphan therapies to market, and provide the services and support patients and caregivers deserve.”
The two-day summit takes place October 15-16. For more information, visit NORD.
Posted on October 3rd, 201810/3/18
CHICAGO – October 3, 2018 – EVERSANA,™ the leading independent provider of global services to the life science industry, today announced the addition of Seeker Health® to its platform. Headquartered in Palo Alto, Calif., Seeker Health offers breakthrough digital patient identification technology to accelerate drug development and commercialization for biopharmaceutical companies. The company excels at […]
Posted on October 2nd, 201810/2/18
EVERSANA, the leading independent provider of global services to the life science industry, is proud to join the rare disease patient community as a sponsor of the Global Genes 2018 RARE Patient Advocacy Summit in Irvine, California, October 3-4. The event is the largest gathering of rare disease patients, advocates and thought leaders, who share […]
Posted on September 30th, 20189/30/18
MILWAUKEE – October 1, 2018 – The fast-growing life science services platform built in partnership with Water Street Healthcare Partners and JLL Partners, today unveiled its new name and brand: EVERSANA.™ Anchored to the Latin word “sana” for healthy and “ever” for continual evolution, the new name reflects the expanding platform’s commitment to advancing life […]